Pascal Poignard

18.1k citations
103 papers · 15.7k · 8 hit papers · h-index 54

Impact in

Papers in

    • HIV Research and Treatment 79
    • SARS-CoV-2 and COVID-19 Research 11
    • COVID-19 Clinical Research Studies 4

Pascal Poignard

102 papers receiving 15.4k citations

Pascal Poignard's Hit Papers

Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys 2013 · 549 citations
5490+5+11Years since publication4008001.2k

Peers

Pascal Poignard
Comparison fields: 5 of 110
  • Virology 11.8k
  • Radiology, Nuclear Medicine and Imaging 1.2k
  • Immunology 996
  • Infectious Diseases 898
  • Molecular Biology 1.4k
Replace Mark K. Louder with:
Mark K. Louder United States
Hua‐Xin Liao United States
S. Munir Alam United States
Jean‐Philippe Julien Canada
Per Johan Klasse United States
James A. Arthos United States
Rogier W. Sanders Netherlands
Mark Connors United States
James E. Robinson United States
Michael B. Zwick United States
Pascal Poignard relative to Mark K. Louder United States Mark K. Louder's profile →
Citations per field
00.5×1.5×
Mark K. Louder · 1×
Citations per year

Countries citing papers authored by Pascal Poignard

Since Specialization
Citations

This map shows the geographic impact of Pascal Poignard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Poignard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Poignard more than expected).

Fields of papers citing papers by Pascal Poignard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Poignard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Poignard. The network helps show where Pascal Poignard may publish in the future.

Co-authors

The 25 scholars most cited alongside Pascal Poignard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pascal Poignard Line = papers co-authored together Pascal Poignard links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
Hit paper breakdown →
20091484
2
Broad neutralization coverage of HIV by multiple highly potent antibodies
Hit paper breakdown →
20111287
3
Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
Hit paper breakdown →
2011997
4
Human Circulating PD-1+CXCR3−CXCR5+ Memory Tfh Cells Are Highly Functional and Correlate with Broadly Neutralizing HIV Antibody Responses
Hit paper breakdown →
2013719
5
A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
Hit paper breakdown →
2011623
6
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys
Hit paper breakdown →
2013549
7 2009491
8 2009478
9 2009439
10
Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo
Hit paper breakdown →
2012417
11
Broadly Neutralizing Antibodies Present New Prospects to Counter Highly Antigenically Diverse Viruses
Hit paper breakdown →
2012364
12 2014322
13 2003316
14 2010314
15 2014304
16 2014285
17 1993282
18 2016281
19 2009280
20 2013258

About Pascal Poignard

Pascal Poignard is a scholar working on Virology, Infectious Diseases, Radiology, Nuclear Medicine and Imaging, Immunology and Parasitology, having authored 103 papers that have together received 15.7k indexed citations. Recurring topics across this work include HIV Research and Treatment (79 papers), SARS-CoV-2 and COVID-19 Research (11 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), T-cell and B-cell Immunology (5 papers), COVID-19 Clinical Research Studies (4 papers), Complement system in diseases (2 papers), Genomics and Phylogenetic Studies (2 papers) and Toxoplasma gondii Research Studies (2 papers). The work is most often cited by research in Virology (11.8k citations), Radiology, Nuclear Medicine and Imaging (1.2k citations), Immunology (996 citations), Infectious Diseases (898 citations) and Molecular Biology (1.4k citations). Pascal Poignard has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Dennis R. Burton, Paul W.H.I. Parren, Ian A. Wilson, Quentin James Sattentau, Ann Jones Hessell, David I. Watkins, Eva G. Rakasz, Robyn L. Stanfield, John P. Moore and Lars Hangartner. Their work appears in journals such as Journal of Virology, Immunity, PLoS Pathogens, Proceedings of the National Academy of Sciences and Nature.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact